KESTINLYO 10 mg, lyophilizate oral 30 oral lyophilisates
Active ingredients: Ebastine
Commercialized according to BDPMDispensing in France: Prescription only
Lyophilizate30 oral lyophilisatesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KESTINLYO 10 mg, lyophilisat oral
- Pharmaceutical form
- lyophilisat
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC polyamide aluminium de 30 lyophilisat(s)
- Marketing authorisation holder
- ALMIRALL
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 10 Mar 2006
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64579019CIP73675916CIP133400936759169Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉBASTINElyophilisat | 10 mg · un lyophilisat | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.